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Abstract 
Objective: Improving end-of-life care for people with neurodegenerative diseases is seen as a 
clinical priority. In order to do this, it is important to take into account the views expressed by 
people with these conditions on their experiences of this care. The purpose of this review was to 
provide a thematic synthesis of the views of adults with neurodegenerative diseases on end-of-
life care. 
Methods: After a systematic search, 13 articles were included and thematic synthesis was used to 
collate and interpret findings.  
Results: Four analytical themes were identified; 1) Importance of autonomy and control; 2) 
Informed decision-making and the role of healthcare professionals; 3) Contextual factors in 
decision-making; 4) The pitfalls of care.  
Conclusion:  Participants’ views were framed by the context of their lives and experience of their 
illness and these shaped their engagement with end-of-life care. Given the varying disease 
trajectories, care needs to be individualised and needs-based, implementing palliative care in a 
timely way to prevent crises and loss of autonomy. 
 
Keywords: Neurodegenerative disease, end-of-life care, palliative care, qualitative, 
metasynthesis,  
  
       
 
Introduction 
Improving end-of-life care (EOLC) is a significant health care priority worldwide, 
particularly as individuals are living longer with conditions which previously significantly 
shortened lifespan. Palliative care offers a theoretical model of EOLC for people with life-
limiting conditions and is promoted by the World Health Organization as the preferred approach 
(Wolrld Health Organization, 2002). Conceptually, the aim of palliative care is to improve the 
quality of life of patients with life-threatening illnesses and their families by providing 
compassionate care that emphasises the importance of attending to individuals’ psychological 
and spiritual needs as well as the physical aspects of dying (Morrison and Meier, 2004). 
Accordingly, central importance is placed on the wishes of the dying individual. Effective 
palliative care has three main aims: management of physical symptoms and side effects; 
continuing communication of treatment goals between doctor, patient and family; and 
psychological, spiritual and social support for patient and family. 
Neurodegenerative diseases 
A systematic review by Zimmermann, Riechelmann, Krzyzanowska, Rodin, and Tannock 
(2008) demonstrated that palliative care approaches improve family satisfaction with care for 
people with chronic conditions. However, access to palliative care is predominantly restricted to 
people with cancer (Solano, Gomes, & Higginson, 2006). Indeed an important group of patients 
who have not benefitted fully from effective EOLC are those with neurodegenerative diseases 
such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and 
motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS). Although 
distinct conditions, these can be described as largely adult-onset and characterised by progressive 
loss of structure or function of neurons, including neuronal cell death (Ross and Poirier, 2004). 
       
 
They also share a number of characteristics, such as progressive loss of functioning in a range of 
domains, although rate of deterioration is varies.It is estimated that, since 2002, chronic 
conditions (including degenerative diseases) have been the largest cause of death globally 
(World Health Organization, 2008). Despite their capacity to cause significant morbidity and 
shorten life, neurodegenerative diseases are not typically associated with palliative care 
(Luddington, Cox, Higginson, & Livesley, 2001) 
Moreover, research suggests that the quality of EOLC for people with neurodegenerative 
diseases is often poor (Bede et al., 2011; McGarva, 2001). This is in spite of the fact that people 
with neurodegenerative diseases are often aware in advance that their cognitive abilities and 
capacity for communication will decline and for some (e.g. MND) the time from diagnosis to 
death is relatively short. Of course it is possible that there are significant challenges with the 
implementation of palliative care in this population. Disease trajectories for neurodegenerative 
diseases are more variable, ranging from months to decades, and so prognosis can be uncertain 
(Lindenberger and Meier, 2013). A further barrier may be the belief that palliative care should 
only be offered at the end stage of an illness (Kristjanson, Toye, & Dawson, 2003). However, 
due to the broad scope of palliative care, it can in principle be integrated with curative treatment 
and need not preclude life-prolonging treatments.  
However, in order for care to be best provided, a range of research is needed to create an 
effective evidence base and this includes qualitative research as this can focus on views and 
experiences in a way that meta-analyses cannot. It is particularly important that views from 
patients (as opposed to professionals) are emphasised as it has been shown in other research 
(e.g., in the assisted dying debate: see Duncan, & Parmelee, 2006) that views on what is seen as 
optimal care differ between groups. It is also useful to note that as the push for palliative care to 
       
 
be provided for people with NDDs is increasing, producing a synthesis on patient views is 
timely. Services need to develop which meet the needs of patients. As some conditions (e.g., 
HD) are relatively rare, the synthesis can also help provide evidence in the absence of a separate 
and sufficient corpus of research for each condition. Consequently, it was decided that it was 
timely and necessary to conduct a qualitative meta-synthesis to explore the views of people with 
neurodegenerative diseases on EOLC. 
Method 
Data collection 
A systematic search of four electronic databases (Academic Search Complete, PubMed, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) and PsycINFO) was 
conducted in January 2016. In order to identify search terms, the research question was separated 
into its essential parts: neurodegenerative diseases and EOLC. Search terms were generated 
based on these two areas (see Table 1) and refined using the index terms for each database (for 
example, subject headings, APA descriptors, database thesauruses and the MeSH ‘explode’ 
function was used in databases where this was an option). The search terms were combined  
using the Boolean terms ‘and’ and ‘or’.  
Insert Table 1 about here 
 
Inclusion and exclusion criteria 
The selected studies were screened using the following inclusion criteria: papers must 
include   (a) participants with an adult onset neurodegenerative disease (multiple sclerosis, 
despite being more controversial, was also included (e.g., Chaudhuri, 2013).  (b) explored 
participants’ views in relation to EOLC (either as a whole experience or in relation to specific 
       
 
care practices), either through their actual experience or their views on its availability and/or 
quality; (c) reported findings of qualitative research using recognised methods of data collection 
and analysis, (d) been available in English and (e) been published in a peer-reviewed journal.  
Neurodegenerative disorders are one of the most problematic classifications of disease 
(Du and Pertsemlidis, 2011). The focus here was on progressive disease processes which affect 
specific neurons in specific functional anatomical systems (Przedborski, Vila, & Jackson-Lewis, 
2003) and are not due to an external cause.  Consequently, studies were excluded which focused 
on a) neoplasm, oedema, haemorrhage, and trauma of the nervous system or infection or 
poisoning (Przedborski, et al., 2003).   
The first author initially assessed the titles and abstracts, and full text studies were 
obtained and screened.  Studies that focused on the perspective of caregivers, family members, 
or healthcare professionals were excluded unless patients’ views were reported separately.  
Sandelowski and Barroso (2003) suggest a classification system for appraising the depth of 
analysis. Consistent with the recommendations of this system, ‘no-finding’ studies (e.g. articles 
consisting of uninterpreted narratives or diaries) and topical survey studies were excluded. To 
illustrate, a single case report (Mitsumoto and Rabkin, 2007) was excluded, despite its use of rich 
quotes, because no qualitative analysis was evident and it was considered a ‘no-finding’ study. 
Figure 1 summarises the application of the inclusion and exclusion criteria to the papers found. 
Insert Figure 1 here 
Critical appraisal 
The quality of each study was appraised using the Critical Appraisal Skills Programme (CASP) 
checklist for qualitative research (Critical Appraisal Skills Programme, 2017) to identify 
potential limitations. A three-point numerical scoring system was used, developed by Feder, 
       
 
Hutson, Ramsay and Taket (2006), whereby papers were given a score of 0-2 on each of the 
CASP’s 10 items. . The purpose of this appraisal was not to exclude studies (Bondas and Hall, 
2007) but to give weighting to their contribution in the synthesis (Topcu, Buchanan, Aubeeluck, 
& Garip, 2016). However, all papers scored sufficiently highly and none of the papers were 
given less emphasis (see Table 2).  
Characteristics of the selected studies 
The 13 selected studies had sample sizes ranging from 2-34 people. Diagnoses included 
HD (n = 1), MND (n = 7), MS (n = 2), dementia (n = 1) and PD (n = 2) and participants varied 
widely in stage of disease. Seven of the selected studies used semi-structured interviews, one 
study used narrative interviews (employing a variety of modes of communication including 
email, diary and telephone), three studies did not detail the structure of their interviews, 
describing them as ‘in-depth interviews’, one study reportedly used ‘episodic face-face 
interviews’ and one study used autobiographies. Four of the selected studies used grounded 
theory, three studies thematic analysis, three studies content analysis, one study used the 
‘constant comparison method’ and two studies used phenomenological based approaches to 
analysis. 
The data collection for the studies took place in a variety of settings, predominantly 
individuals’ homes, but also hospitals, outpatient clinics, hospices and nursing homes. Two 
studies used the same participants (Foley, Timonen, & Hardiman, 2013, 2014); however, they 
each provided a novel set of findings that were complementary and, consequently, both studies 
were included in the metasynthesis. Studies came from a number of countries, perhaps not 
surprisingly all more associated with a more advanced approach in palliative care: United 
Kingdom (n = 3), Australia (n = 2), Canada (n = 2), Germany (n = 2), Ireland (n = 2), 
       
 
Netherlands (n = 1), and Sweden (n = 1). See Table 2 for more in-depth characteristics of the 
studies. 
Insert Table 2 about here 
Data extraction, analysis and synthesis 
 
An inductive thematic synthesis approach (Thomas and Harden, 2008) was used to 
synthesise the original content of the studies and produce a more advanced understanding 
through interpretive themes. This approach was chosen due to its emphasis on synthesising the 
content of the individual papers’ themes as opposed to assessing their linguistic structure. The 
approach also privileges the development of more analytic themes as opposed to the collection of 
similar content. The three conceptual stages of thematic synthesis were followed: the ‘line-by-
line’ coding of text; the development of descriptive themes; and the generation of ‘analytical 
themes’. Each paper was read and re-read so that the first author became familiarised with and 
immersed in the data. Reflective notes were kept at this stage to enhance depth of understanding. 
The studies were then coded, much as they would be in primary qualitative research, to capture 
the themes within the original studies relating to the review question on people’s views on end-
of-life care.  
The codes were then analysed, identifying differences and similarities between them, to 
generate an initial set of descriptive themes. These descriptive themes did not attempt to 
reinterpret the primary findings; closeness to the original data sets is essential in this secondary 
analysis. These themes were considered to extract the meaning of studies in a consistent way that 
was close to the original interpretations of the respective authors.  
Finally, more interpretative analytical themes were refined from the descriptive themes 
by the first author and then developed by the fourth author. These analytical themes are more 
       
 
tacit, abstract entities and attempt to capture the essence of the data (DeSantis & Ugarriza, 2000). 
The contribution of each paper to each analytical theme is provided in Table 3.  
Insert Table 3 about here 
Results 
Four analytical themes were identified in the analysis of the interview data.  
Importance of autonomy and control 
A strong sense of the importance of autonomy and control ran through participants’ 
accounts. For example, participants wanted to take an active role in decision-making about their 
care. Although there was wide variation in individuals’ wishes (for example, for life-prolonging 
treatments, for hastened death, or for preferred place of death), participants were clear that these 
views should be respected and they should be involved in reaching a final decision. ‘And I would 
like to know how it will be managed and what my choices are’ (Whitehead, O’Brien, Jack, & 
Mitchell, 2012, p. 372). Desire for autonomy and control occurred in the context of the 
participants’ feeling that they had reduced control over many aspects of their lives as a result of 
their illnesses. Participants were acutely aware of the progression of their neurodegenerative 
disease and spoke about this affecting their ability to make active decisions. For example, some 
people felt that their choices about medical interventions were restricted because of their 
condition. ‘It’s not a choice, you either use it or can’t breathe of a night, so there is no choice.’ 
(Greenaway et al., 2015, p. 1005). Conversely, other participants felt reassured by making active 
decisions about their care, though sometimes they had to fight to obtain this. 
I felt absolutely no control so I said to them [healthcare  professionals] ‘I feel a complete 
disconnect ... [that] I’m kind of apprehensive about a lot of things’ ... now I am connected 
and it’s a team effort. Now I’m able to sit down and discuss it [EOLC] with them ... make 
decisions when you are in control [of care] (Foley, et al., 2014, p. 321) 
       
 
Loss of autonomy was associated with diminished quality of life and meaningfulness.  
I asked about a possible trache [tracheotomy] and ventilator for the future. He said a 
definite ‘NO’, he wouldn’t advise it and neither would the other consultant there….But 
what about what I want!!!! That didn’t seem to matter… I feel useless and as if my life 
isn’t even worth talking about (Whitehead, et al., 2012, p. 372) 
Other participants questioned the value of life-prolonging treatments given the life-
limiting nature of their neurodegenerative diseases, perceiving that interventions could 
potentially prolong suffering. This was seen as unacceptable and participants talked about 
disengaging from care, for example, by refusing life-prolonging treatments and supportive care, 
when this was anticipated. For this group, autonomy over when and how to engage with their 
care was more important than extending their life.  
There were a range of views on assisted dying and euthanasia. Ending life in this way 
was chosen by some participants in countries where these were legal, and wished for in countries 
where these were not. For others, assisted dying and euthanasia were antithetical to their 
principles and therefore rejected. However, for all self-determination was important, regardless 
of their beliefs or personal intentions.  
Informed decision-making and the role of healthcare professionals  
 
This theme conceptualised the information needs of participants and their, often implicit, 
belief that health care professionals were responsible for meeting these. Many participants spoke 
about a lack of information about their care, which inhibited their ability to make fully informed 
choices. ‘I didn’t get the brochures or anything from the doctors… there’s really not much there 
to help (Giles and Miyasaki, 2009, p.121). Similarly, some participants felt that there was a lack 
of awareness of their neurodegenerative disease, even among health professionals, which added 
       
 
to their feelings of frustration. Some participants talked about managing the lack of information 
from healthcare professionals by actively seeking out information (e.g. from the internet). A 
smaller number of participants, in contrast, felt that they had all the information they needed, 
which enabled them to make confident decisions. ‘They covered everything I wanted to know 
and the questions they asked were the right questions’ (Poppe, Burleigh, & Banerjee, 2013, p. 3). 
Generally, there was ambivalence within and across studies over how much information 
was enough. Many participants wanted information to be able to make decisions about their care 
but reported anxiety about the prospect of a bleak prognosis. Fear of confronting their potential 
deterioration and death meant that some participants rejected advanced care-planning 
discussions, finding them futile or dispiriting. This variability in individuals’ information needs 
illustrates the complex task facing healthcare professionals. 
 Most participants valued their experiences of advanced care planning, finding it a helpful 
experience that gave them important information, the opportunity to have significant 
conversations with loved ones, alleviated their worries about their care in the future and 
reassured them that their wishes would be honoured.  
I decided to make arrangements and things so if anything happens now they all know, 
what I want and what’s happening so it saves me worrying about it (Poppe, et al., 2013, 
p. 3)  
Similarly, participants disclosed their reticence in discussing EOLC. Many participants 
expressed their wish to have open conversations about EOLC but not knowing what to ask for or 
feeling able to raise this difficult topic. Accordingly, their expectations of care were not met.  
       
 
Participants wanted a trusting relationship with their healthcare professionals and felt 
more reassured about their care when this was realised. Trust was placed in healthcare 
professionals when support and empathy were offered as well as sensitivity to their needs.  
I was concerned that it was actually something that would help me but could weaken my 
ability in the daytime. And it really reassured me that actually it would make it better. 
That was what I wanted to hear (Greenaway, et al., 2015, p. 1007). 
It is possible that trust is a key determinant of participants’ satisfaction and presupposes 
other factors that comprise good care. Noticeably, when trust was not present participants across 
studies appeared to be silent and disengaged from their care.  
 
Contextual factors in decision-making 
 
Participants across studies communicated the importance of contextual factors in their 
EOLC. Family, for example, played a central role in decision-making. Most participants saw 
their neurodegenerative disease in a family context and frequently discussed their preferences for 
EOLC with family members and came to decisions endorsed by the family. A prominent desire 
for participants was not to be a ‘burden’ on family members. However, it was also important for 
participants to ‘be there’ for families to support and be supported by them. This demonstrates the 
complexity of decision-making. Family could be supportive but also demanding and participants 
often struggled to balance their personal needs with those of the family unit. At times this 
resulted in complex emotions and participants feeling restricted in their decision-making about 
care. For example, on considering assisted suicide one participant commented:  
I had to consider my family and the implications. It’s like a suicide… the pebble in the 
water. It spreads out. (Foley, et al., 2014, p. 72). 
       
 
Family influenced not only decision-making but practical care. For example, some participants 
refused paid carers because family members occupied that role. These participants spoke about 
the importance of reciprocal family support. Alternatively, where participants had no family to 
take into account, this influenced their choices. ‘You see, I don’t feel I have the need to hang on 
at any cost. If I had a husband, wife, children, it might be different. So I’m free to make the 
choice.’ (Foley, et al., 2014, p. 72). 
Another important contextual factor was participants’ perceived status in comparison 
with others. Frequent social comparisons were made in order to form opinions on care. These 
were often first-hand experiences, such as family members’ experiences of the end stages of 
neurodegenerative disease: ‘Not the way my mother suffered’ (Booij, Rödig, Engberts, Tibben, 
& Roos, 2013, p. 326). Having witnessed a parent or other family member affected by the same 
neurodegenerative condition seemed to shape participants’ wishes for end of life. 
 The variability of disease progression complicated decision-making for participants. 
Many participants were acutely aware of situations, points in their trajectory, that they felt would 
be unbearable and lead them to seek means to hasten their death: ‘As soon as I become 
dependent on others, then it is time to pull the plug’ (Booij, et al., 2013, p. 326). The concept of 
time therefore influenced participants’ views on EOLC. Some participants made the conscious 
choice to ‘live in the moment’, which meant decisions on interventions represented that 
particular situation in time. However, participants were aware that they might change their mind 
in the future and revisit these decisions. ‘I was going to write a living will but I’ve decided with 
my GP [general practitioner],  now that there’s no point really, if I wrote a living will now you 
might want to change your mind.’  (Whitehead, et al., 2012, p. 327). 
       
 
 Some participants held on to hope that the future might hold different options for care. 
This sense of hope sustained them in adjusting to the ramifications of their neurodegenerative 
diseases and engaging with their EOL care. ‘[I’ve] just got to stay fit and healthy and exercise, 
take my medication and hope… they have some luck with the stem cell testing’ (Hudson, Toye, 
& Kristjanson, 2006, p. 89).  
 
The pitfalls of care  
 
Participants described varied and individualised care needs, including emotional, physical 
and practical support. Often the care received was inadequate and viewed as difficult to access 
and a demanding experience: ‘And now I get pats on the cheek or, worst of all, on the head, like 
a child. So I hate it. That patronizes compassion. So far from compassion and empathy’ 
(Rosengren, Gustafsson, & Jarnevi, 2015, p. 79). 
Often the promise of care was different from the reality and participants were left 
disappointed by the service they received. One participant spoke about how support groups, 
designed to provide psychosocial support, were unhelpful.  
I guess I don’t really need to be around people like that at this stage… what are you going 
to do? Sit around and talk about how much you shake at night… it might tend to be a 
little depressing for the type of person that I am at the moment (Hudson, et al., 2006, p. 
90). 
Accordingly, specialist support services were highly valued, where healthcare 
professionals were well informed about their disease and able to provide continuity of care. ‘If I 
have any questions I visit the professor. And my GP, he doesn’t really know about the disease’ 
(Booij, et al., 2013, p. 328).  
       
 
Often negative emotions were associated with the inadequacy of care. However, many 
participants seemed resigned to the fact that care could not meet all of their needs. For example,  
some participants expressed a need for meaningfulness. This involved staying connected to other 
people and their  own values. This was least commonly met by healthcare professionals and 
perceived as an inappropriate conversation topic. 
Those are pretty private things, like attitude towards life or further progress or whatever, 
and all those things you can talk about for hours, and I think that’s why the doctor doesn’t 
even bother getting into all that. Instead it’s just acute problems, and that was it 
(Galushko et al., 2014, p. 278).  
Many participants expressed a wish to die at home. For them, home was a meaningful place of 
care where family could support them and sadness was expressed at the thought of this not being 
possible. ‘With a tracheostomy, I’m stranded to a nursing home.’ (Lemoignan and Ells, 2010, p. 
211). This demonstrates how participants questioned the meaning of interventions and made 
decisions about them based on their own values and goals. 
 
Discussion 
The aim of this synthesis was to collate the views of adults with neurodegenerative conditions on 
end of life care; end of life care for this group is a growing clinical priority and it is important to 
understand and position these individuals as key stakeholders in the development of appropriate 
services.   A systematic search process found 13 articles suitable for inclusion and these were 
analysed using a form of thematic synthesis.  
 
       
 
This synthesis has revealed a number of important empirical and clinical insights into how 
people with neurodegenerative diseases viewed EOLC. Moreover, while no claims are made of 
generalisability across all neurodegenerative diseases, the views within and across studies and 
disease conditions were remarkably similar. Empirically, the themes ‘Importance of autonomy 
and control’ and ‘Informed decision-making and the role of healthcare professionals  
 are consistent with existing research into patient preferences for healthcare. These findings 
confirm the results of a systematic review (Kiesler and Auerbach, 2006) exploring matching 
patients’ preferences for information, decisional control, and consultative interpersonal  style. 
This found that patients vary in how active a role they play in their healthcare and how much 
responsibility they wish to take over decisions made. When the interactional styles of healthcare 
professionals and their patients do not align, outcomes such as effectiveness of treatment and 
patient satisfaction are negatively affected. The researchers suggest that healthcare professionals 
should not interact with patients in a rigid, standardised way but in a manner that matches 
patients’ preferences for information and involvement in decision-making.  This key finding in  
this metasynthesis - that many participants were dissatisfied with the information given about 
their EOLC - fits with research suggesting that healthcare professionals tend to be poor at 
communicating about end-of-life issues (Milberg and Strang, 2000). 
Empirical evidence on neurodegenerative diseases supports the significance of autonomy 
and the notion that patients wish to be informed and actively involved in their care (e.g., Joffe, 
2003; Tramonti, Bongioanni, Di Bernardo, Davitti, & Rossi, 2012). However, it is noteworthy 
that some people want little or no role in decision-making (Benbassat, Pilpel, & Tidhar, 1998; 
Say, Murtagh, & Thomson, 2006) and a minority of participants in this synthesis preferred 
healthcare professionals to make decisions about their care. It is possible to view this in a 
       
 
positive way, as individuals paradoxically exercising their autonomy and control by giving their 
responsibility for decision-making to healthcare professionals. However, Rodin, Timko and 
Harris (1985) suggest that people who perceive less self-control tend to take less accountability 
for their health, be less likely to make use of health protective behaviours and have lower 
immunological response. Certainly perceived loss of control is a feature in neurodegenerative 
diseases  and the need to reassert control when uncertainty and lack of control are so evident is a 
prominent characteristic for many (Eccles and Simpson, 2011).  
From a clinical perspective, the shortcomings in care identified by participants were 
largely related to their psychosocial needs rather than unmet biological or medical needs. Despite 
the widespread acceptance of the biopsychosocial model of health (Engel, 1980) and subsequent 
move towards the delivery of holistic healthcare, Brown, Alaszewski, Swift, and Nordin (2011) 
argue that the purpose of medicine is still perceived to be to correct the ‘problematic body’. Yet 
evidence from this review suggests that this conceptualisation is at odds with the needs of 
patients. For example, recent studies (Chiò et al., 2004; Ho, Gilbert, Mason, Goodman, & 
Barker, 2009; Simpson, Lekwuwa, & Crawford, 2014; Yamout et al., 2013) have found that 
mental health variables were more influential than physical ones in determining health-related 
quality of life in people with neurodegenerative disorders. Consequently, a palliative care 
approach would be beneficial to many people with neurodegenerative disease. Timing is 
important as some participants reflected that they wished to ‘live in the moment’ and the disease 
trajectory of many neurodegenerative conditions is long. Therefore, although it is generally 
beneficial to involve care early, an individualised approach is needed, with high quality care 
provided over time at the degree to which it is required. More widely, this will require a shift in 
care provision from the more common model of crisis management to a framework of chronic 
       
 
care, incorporating palliative care, which is often lacking, particularly for non-cancer conditions 
(Siouta, van Beek, Preston, et al., 2016; Siouta, Van Beek, van der Eerden, et al., 2016). This 
should include anticipating disease milestones and addressing them in a timely way to prevent 
crises and loss of autonomy.  
In terms of review limitations, the studies included were restricted to those in the English 
language; relevant studies in other languages may exist. However, Doyle (2003) argues that the 
sample for qualitative review is justifiably purposive, not exhaustive because the aim is 
interpretation, not prediction.  
Additionally, although the synthesis found consistency across papers and neurodegenerative 
diseases share many features, they are heterogeneous conditions. For example, the median life 
expectancy for MND is 2–5 years after diagnosis (Mitchell & Borasio, 2007) whereas HD is 
around 20 years (Simpson, 2007). It is possible that some views on end-of-life care, such as 
around desire for hastened death, might differ between these populations and it would be useful 
to explore this further. At the moment, given the greater number of studies involving people with 
MND – which has the shortest life expectancy after diagnosis - in this review, it is possible that 
this has overly influenced the analysis.  
 
 In conclusion, this synthesis offers an enhanced understanding of the views of people 
with neurodegenerative diseases on EOL care by providing a higher level of analysis than what 
would be gleaned from individual studies. This synthesis highlights that the care needs of people 
with neurodegenerative diseases are often not met, that autonomy and a sense of control are key, 
that views are contextual and local, and that specific illness belief factors (such as the meaning 
participants make, their beliefs and their preferences for information) shape engagement with 
       
 
care. Also, this synthesis promotes the importance of social context and recommends that care 
should be individualised, placed in the context of the life of the individual and implemented in a 
needs-based, integrated way across the disease trajectory as opposed to a traditional, symptom-
led approach. From these studies  it is not possible to determine if it is a lack of palliative care 
services that is the difficulty for individuals or if palliative care services need to improve (there is 
certainly some evidence of both across the papers). Indeed an area for more research would be in 
focusing only on the experiences of those who are receiving palliative care and a focus on those 
for whom the system has worked well. 
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Table 1. Final search terms for each database. 




(DE "NEURODEGENERATION") OR (DE "HUNTINGTON'S chorea") 
OR (DE "PARKINSON'S disease") OR (DE "AMYOTROPHIC lateral 
sclerosis") OR (DE "ALZHEIMER'S disease") OR (DE "MULTIPLE 
sclerosis-- Treatment") OR (DE "MOTOR neuron diseases") 
 AND (DE "TERMINAL care" OR DE "HOSPICE care" OR DE 
"PALLIATIVE treatment") 
CINAHL (MM "Neurodegenerative Diseases+") OR  
(MM "Multiple Sclerosis+")  
 AND (MM "Palliative Care") OR (MM "Terminal Care+") OR (MM 
"Hospice Care") OR (MM "Hospice and Palliative Nursing") 
PubMed ("Neurodegenerative Diseases"[Mesh]) OR "Multiple Sclerosis"[Mesh]) 
 AND (((("Palliative Care"[Mesh] OR "Hospice and Palliative Care 
Nursing"[Mesh]) OR "Terminal Care"[Mesh]) OR "Hospice Care"[Mesh])) 
PsycInfo ("Neurodegenerative Diseases"[Mesh] OR "Multiple Sclerosis"[Mesh]) 
AND ((("Palliative Care"[Mesh] OR "Hospice and Palliative Care 
Nursing"[Mesh]) OR "Terminal Care"[Mesh]) OR "Hospice Care"[Mesh]) 
 AND ("Neurodegenerative Diseases"[Mesh] OR "Multiple 
Sclerosis"[Mesh]) AND ((("Palliative Care"[Mesh] OR "Hospice and 







Table 2. Summary information of the studies included in the metasynthesis 
1st Author, Title, Year and Country Aims Method Analysis (Total) number, 








Booij. Euthanasia and advance 
directives in Huntington’s disease: 
Qualitative analysis of interviews 
with patients (2013, The 
Netherlands) (Booij, et al., 2013) 
To obtain in-depth information about 
patients’ thoughts on and attitudes to 
euthanasia, physician-assisted 
suicide and the use of advance 
directives in Huntington’s Disease 
Semi-structured in-depth 
interviews 
Qualitative analysis based 
on grounded theory 
(14) 8 women, 
28-70 
Background of EOL 
issues, presence of 
wishes, knowledge of 
advance directives, role of 
family and physician 
18 
Burchardi. Discussing living wills. 
A qualitative study of a German 
sample of neurologists and 
amyotrophic lateral sclerosis 
patients (2005, 
Germany)(Burchardi, Rauprich, 
Hecht, Beck, & Vollmann, 2005) 
To investigate how neurologists 
provide information about living 
wills to Amyotrophic Lateral 
Sclerosis patients. To explore if 
discussions met patients’ needs and 
expectations. 
Semi-structured interviews Grounded theory 
techniques 
(15), 5 women, 
43-78, M= 59 
Healthcare professional 
biases, timing of 
interventions, importance 
of choice, importance of 
trust, desire to hasten 
death, aim to reduce 
suffering, future decline 
 
16 
Foley. Acceptance and decision 
making in amyotrophic lateral 
sclerosis from a life-course 
perspective (2013 Ireland) (Foley, et 
al., 2013) 
To identify key psychosocial 
processes that underpin how and why 
people with Amyotrophic Lateral 
Sclerosis engage with services. 
In-depth interviews Grounded theory (34) 17 women, 
37-81,  
Life and death, 
acceptance, family 
context to decision 
making, views on assisted 
dying,  
18 
Foley. Understanding psycho-social 
processes underpinning engagement 
with services in motor neurone 
disease: A qualitative study (2014, 
Ireland) (Foley, et al., 2014) 
To identify key psychosocial 
processes that underpin how and why 
people with motor neurone disease 
engage with services. 
In-depth interviews Grounded theory (34) 17 women, 
37-81,  
Control over care, 
reassurance from 
healthcare professionals, 
importance of trust, 
meaning of life, meaning 
of interventions 
18 
Galushko. Unmet needs of patients 
feeling severely affected by multiple 
sclerosis in Germany: A qualitative 
study (2014, Germany)(Galushko, 
et al., 2014) 
To explore the subjectively unmet 
needs of patients feeling severely 






(15) 9 women, 
23-73, M= 47  
Inadequacy of care, 
family context, trust/lack 




Giles. Palliative stage Parkinson’s 
disease: patient and family 
experiences of health-care services 
(2009, Canada)(Giles and Miyasaki, 
2009) 
To understand the lived healthcare 
experiences of people with 
Parkinson’s and their families and 
the needs flowing from these 
experiences. 
Semi-structured  in-depth  





(2) 2 women, 
75-77, M= 76  
Missing information, 
being on your own, 
meaning and identity 
17 
Greenaway. Accepting or declining 
non-invasive ventilation or 
gastrostomy in amyotrophic lateral 
sclerosis: patients’ perspectives 
(2015, United Kingdom) 
To identify factors associated with 
decisions made by patients with  
amyotrophic lateral sclerosis to 
accept or decline non-invasive 
ventilation or gastronomy 
Semi-structured interviews Thematic analysis (21) 8 women 
women, 41-76 
Perceptions of choice, 
fear, perceived need and 
acceptance, influence and 






(Greenaway, et al., 2015) family context, 
information needs 
Hudson. Would people with 
Parkinson’s disease benefit from 
palliative care? (2006, Australia) 
(Hudson, et al., 2006) 
To describe the experience of 
Parkinson’s disease and consider the 
relevance of palliative care for this 
population 
Semi-structured interviews Thematic analysis (8) 4 women, 
40->80 
Contextual factors, 





Lemoignan.  Amyotrophic lateral 
sclerosis and assisted ventilation: 
how patients decide (2010, Canada) 
(Lemoignan and Ells, 2010) 
To better understand the experience 
of decision-making about assisted 
ventilation for amyotrophic lateral 
sclerosis patients 
Semi-structured interviews Qualitative 
phenomenology 
methodology  
(9) 3 women, 
36-72 
Meaning of intervention, 
importance of context, 
importance of values 
(autonomy), effect of 




Poppe. Qualitative evaluation of 
advanced care planning in early 
dementia (ACP-ED) (2013, United 
Kingdom) (Poppe, et al., 2013) 
To explore the acceptability of 
discussing advanced care planning 
with people with memory problems 
and mild dementia shortly after 
diagnosis 
In-depth interviews Constant comparison 
method 
(12) 8 women, 
68-88, M= 79 
Information needs, 
anxiety about future, 
reassurance from 
healthcare professionals,  
14 
Rosengren. Every second counts: 
Women’s experience of living with 
amyotrophic lateral sclerosis in the 
end-of-life situations (2015, 
Sweden) (Rosengren, et al., 2015) 
To describe patients’ experiences of 
living with ALS in the end-of-life 
situations 






care needs, context to 
decision making 
12 
Whitehead. Experiences of dying, 
death and bereavement in motor 
neurone disease: a qualitative study 
(2012, United Kingdom) 
(Whitehead, et al., 2012) 
To explore the experiences of people 
with motor neurone disease, current 
and bereaved carers in the final 
stages of the disease and 
bereavement period 
Narrative interviews Thematic analysis (24) 16 women, 
25-84 
Fears for the future, 
Information seeking, 
social and family context, 
life and death, wishes and 
decision making, 
importance of choice, 
influence of healthcare 
professionals, euthanasia 
19 
Wollin. Supportive and palliative 
care needs identified by multiple 
sclerosis patients and their families 
(2006, Australia) (Wollin, Yates, & 
Kristjanson, 2006) 
To identify the supportive needs of 
individuals with multiple sclerosis 
and their families 
In-depth semi-structured 
interviews 
Content analysis (13) 6 women, 
23-55 
Lack of support, tracking 
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N = 1657 
N = 1483 
 
N = 166 
 
Hand searching of reference lists = 0 
papers identified 
N = 13 
61 papers excluded because they 
were not peer-reviewed 
(Unable to limit a PubMed search to 
peer-reviewed or refereed journals) 
174 papers excluded due to not being 
in English. ‘English language’ 
database limiter used. 
1317 papers excluded based on title 
and abstract or removed as duplicates. 
152 papers excluded based on full 
text review due to not: 
(a) exploring the views or 
experiences of participants who have 
an adult-onset neurodegenerative 
disease in relation to EOLC, either 
through their actual experience or 
their views on its availability and/or 
quality or 
(b) reporting findings of qualitative 
research using accepted qualitative 
methods of data collection and 
analysis 
1 papers excluded based on critical 
appraisal 
